BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Tamer Inanc

Tamer Inanc appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
eess.SYphysics.soc-phPopulations and EvolutionQuantitative MethodsSystems and Control

Catalog footprint

What is connected

2works
5topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

Optimal Scheduling of Anticipated COVID-19 Vaccination: A Case Study of New York State

This study aims to determine an optimal control strategy for vaccine scheduling in COVID-19 pandemic treatment by converting widely acknowledged infectious disease model named SEIR into an optimal control problem. The problem is augmented by adding medication and vaccine limitations to match real-world situations. Two version of the problem is formulated to minimize the number of infected individuals at the same provide the optimal vaccine possible to reduce the susceptible population to a considerably lower state. Optimal control problems are solved using RBF-Galerkin method. These problems are tested with a benchmarking dataset to determine required parameters. After this step, problems are tested with recent data for New York State, USA. The results regarding the proposed optimal control problem provides a set of evidences from which an optimal strategy for vaccine scheduling can be chosen, when the vaccine for COVID-19 will be available.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Semi-Blind and l1 Robust System Identification for Anemia Management

Chronic diseases such as cancer, diabetes, heart diseases, chronic kidney disease (CKD) require a drug management system that ensures a stable and robust output of the patient's condition in response to drug dosage. In the case of CKD, the patients suffer from the deficiency of red blood cell count and external human recombinant erythropoietin (EPO) is required to maintain healthy levels of hemoglobin (Hb). Anemia is a common comorbidity in patients with CKD. For an efficient and robust anemia management system for CKD patients instead of traditional population-based approaches, individualized patient-specific approaches are needed. Hence, individualized system (patient) models for patient-specific drug-dose responses are required. In this research, system identification for CKD is performed for individual patients. For control-oriented system identification, two robust identification techniques are applied: (1) l1 robust identification considering zero initial conditions and (2) semi-blind robust system identification considering non-zero initial conditions. The EPO data of patients are used as the input and Hb data is used as the output of the system. For this study, individualized patient models are developed by using patient-specific data. The ARX one-step-ahead prediction technique is used for model validation at real patient data. The performance of these two techniques is compared by calculating minimum means square error (MMSE). By comparison, we show that the semi-blind robust identification technique gives better results as compared to l1 robust identification.

0 citations0 reviewsNo code linkedOpen access